Several strains of group B Streptococcus agalactiae were found to be lethal for young adult rats. When bacteria were heat killed and then injected intraperitoneally into rats, rapid death (14 to 18 h) of the rats occurred, characterized by labored breathing, hemolyzed serum, hemoglobinuria, and subungual hemorrhages. Sections of tissues from these rats failed to reveal the cause of death. Rats injected with toxic or nontoxic strains of group B S. agalactiae had reduced numbers of circulating leukocytes and low serum C3 levels in comparison with those in control rats. The toxic strains of group B S. agalactiae induced dramatic decreases in platelet numbers, and in plasma fibrinogen levels as well, suggesting that the toxicity was due to disruption of the coagulation system. Rapid death in the absence of infection suggests that group B S. agalactiae may have a cell-associated toxin that induces these changes. Such a toxin may be a contributory factor in the high mortality rate associated with group B streptococcal infections of the human neonate.
Group B streptococcus (GBS) is one of the major pathogens for human neonates in the United States (1, 14, 21) . It has become apparent that GBS quite successfully eludes the defense mechanisms of neonates, and even when appropriate antibiotic therapy is provided, up to 50% of infected infants die (1) . Animal models in adult mice (3, 28) , neonatal rats (13) , and embryonic chickens (27) have been developed in an effort to understand the human disease. These models have been useful in exploring the route of infection, the extent of organ colonization after inoculation of GBS, and possible means of protection.
As a result of these studies, several explanations for the high susceptibility of neonates for GBS have been brought forward. In comparison to adults, it appears from human studies (22) and from rat models (5, 7) that newborns are less able to contain an infection because the neutrophil reserves are quickly depleted, leading to a severe neutropenia. To compound this deficiency, neonates may lack specific immunity (i.e., anti-type antibody) to GBS, which has been shown to be protective in animal models of the disease (6, 26) . Additionally, GBS's have a terminal sialic acid residue on the type antigen which can inhibit opsonization of the bacteria (10) . As a result of these factors, bacteria multiply relatively unchecked in newborns so that all organs become rapidly colonized and the bacteria reach high titers. It is at this point that toxic molecules on the surface of bacteria could play a role in the disease initiated by the infection.
The possibility that GBS may produce such toxic molecules has been suggested both by noting the similarities between the symptoms of GBS infection in infants and the symptoms of adults with endotoxemia (11) and by the ability of GBS to enhance the effects of endotoxin (25) . Such a toxin has recently been isolated (24) , and its effects on the pulmonary hemodynamics of adult sheep have been described (16) . We now describe a system in which adult rats injected with large amounts of heat-killed GBS's exhibit symptoms similar to those of infected human neonates.
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These include neutropenia, thrombocytopenia, coagulation disorders, complement depletion, and death. These symptoms in the absence of an active infection suggest that GBS's express a cell-associated toxin which may be responsible in part for virulence of this organism. To investigate this toxicity, age-matched female rats were injected i.p. with 60 ,ug of rhamnose per g of body weight of strain 509 (toxic GBS), strain D136C (nontoxic GBS), or strain D58 (nontoxic GAS) or with PBS (controls). After 6 h, rats were sacrificed, and blood and tissue samples were taken for analysis. Histology of various organs, leukocyte counts, platelet counts, serum C3 levels, and plasma fibrinogen levels from rats of the various groups were compared.
MATERIALS AND METHODS

Animals
General observations. Rats injected with any of the streptococcal strains appeared ill after 2 to 3 h. All rats (except those injected with PBS) appeared inactive and ruffled. Only rats injected with strain 509 had hemolyzed serum and hemoglobinuria.
Histology. Rats injected with a toxic dose of strain 509 were sacrificed after 8 h. Spleens, kidneys, livers, and lungs were fixed in 10% buffered Formalin and subsequently processed for paraffin embedding. Sections taken from these organs and stained with hematoxylin-eosin did not differ significantly from sections from rats injected with the nontoxic GBS and group A streptococcus (GAS) strains. In brief, no pathological changes were noted in the spleens, livers, or kidneys of injected rats. Lung sections showed changes in alveolar structure indicative of minimal interstitial pneumonia, and occasionally emphysema-like pathology (Fig. 1) .
So few leukocytes were present in the blood of rats injected with streptococci that valid differential counts could not be performed on blood smears. However, examination of stained smears suggested that polymorphonuclear cells are preferentially lost from the circulation after injection of streptococci (data not shown). This may be a result of the inflammatory reaction occurring in the peritoneum, or it could be a result of margination of activated neutrophils in the circulation.
Platelet counts. The number of platelets decreased when rats were injected with GAS or GBS (Fig. 2) . However, the most dramatic reduction in platelet numbers was observed in rats injected with the most toxic strain of GBS (509).
Effect of injection of streptococci on serum C3 levels. Peptidoglycan of both GAS and GBS is known to fix complement (10, 15) . Rats injected with whole heat-killed organisms had slightly lower C3 levels than did control rats 6 h after injection ( Table 3 ). The decrease in serum C3 levels was comparable with the toxic and nontoxic GBS strains. These data do not support the hypothesis that the complement cascade mediates the toxicity of strain 509.
To test this conclusion in a different way, we pretreated a group of rats with CVF, artificially lowering C3 levels. At 24 h after treatment with CVF when serum C3 levels were barely detectable by rocket immunoelectrophoresis, rats were injected with a toxic dose of strain 509. Six of eight treated rats died within 24 h as compared with five of eight deaths in the control (non-CVF-treated) group. It appears that serum C3-depleted rats were as susceptible to the toxicity of strains 509 as were normal rats.
Plasma fibrinogen levels. The dramatic drop in circulating platelets in rats injected with strain 509 suggested that the clotting system might be activated by toxic GBS strains. A decrease in the fibrinogen content of plasma could have been interpreted to indicate that conversion of fibrinogen to fibrin had occurred and that fibrin clots might have formed. We measured fibrinogen levels in the plasma of rats which had been injected 8 h previously with PBS, GBS strain 509, GBS strain D136c, or GAS strain D58. Rats injected with strain 509 had decreased plasma fibrinogen levels as compared with rats injected with nontoxic GBS or GAS strains (Table   4 ). This hypofibrinogenemia, in conjunction with the severe thrombocytopenia, suggests that a coagulopathy may mediate the toxicity of GBS strain 509. (2, 14) . Early-onset infection is associated with an acute onset of respiratory symptoms and high mortality rates, whereas delayed-onset infection is associated with infection of the meninges and lower mortality rates. The early-onset infection has symptoms similar to those of adults suffering from gram-negative endotoxemia (11) in that gram-negative sepsis has been shown to result in decreases in complement components (12, 20) and clotting factors (18, 19) , as well as in neutropenia and thrombocytopenia (19) . Because of similarities in the response of neonates to GBS infections and that of adults to gram-negative sepsis, it has been postulated that S. agalactiae may elaborate a toxin with effects similar to those of endotoxin. Recently, a substance has been isolated from GBS which causes granulocytopenia and lung vasculature changes in adult sheep (16, 24) and which may represent a cell-associated toxin of GBS. The Another factor which was shared by nontoxic and toxic GBS strains was the induced decrease in complement levels in injected rats. This decrease in complement activity has also been noted in infants infected with GBS (11) . Both GBS and GAS have been shown to fix complement through the alternate pathway (10, 15) . This may affect the processing of antigens and possibly the inflammatory processes induced by these organisms, but it is doubtful that activation of the complement cascade provides a sufficient explanation for the toxic effect on adult rats in this system. This is further corroborated by the data showing that rats which were pretreated with CVF to artificially decrease C3 levels were not protected from toxicity.
Effects on the coagulation system seemed to be a property of the toxic GBS strain and not of the nontoxic strain tested here. After injection of GBS, platelet numbers decreased dramatically in rats which had been injected with toxic GBS strains. These data suggest that a change in the coagulation system had occurred. When plasma fibrinogen levels were assayed by rocket immunoelectrophoresis, it was found that rats injected with toxic GBS had lower levels than did rats injected with the nontoxic strain. Human neonates infected with GBS have been shown to have various coagulopathies, such as hypofibrinogenemia and decreased clotting times and platelet levels (23) . In addition, hemorrhage and intravascular clots have been observed in tissues from some infants who died from GBS sepsis (17, 23) . The effect of the depletion of fibrinogen in the rats in this study is unknown. Pretreatment of the rats with heparin did not protect the rats against the toxicity. Also, fibrin clots were not observed in any of the major organs of these rats at the time of death. The absence of such clots may indicate that the fibrinolytic system, as well as the clotting system of plasma, was activated and that the fibrin clots were being dissolved as soon as they had formed.
Although adult humans are capable of successfully resisting GBS infections, neonates are subject to a high mortality rate. In this paper we describe a model in adult rats in which heat-killed GBS strains can cause an acute illness and death within 14 to 18 h. This is apparently due to some type of cell-associated toxin. It is impossible to know from our data whether this is the same substance described by Hellerqvist et al. (16) . The use of the model in adult rats may be helpful in further defining the human neonatal disease and its relation to a toxin produced by GBS.
